- Proceeds to be used for development of new cultivation and processing project in New Brunswick
- A boost to operating capital
- Canada plans to legalize the extraction of cannabinoids from hemp in mid-2018
- Market for hemp CBD products is predicted to grow to $450 million by 2021
Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets, announced on March 7, 2018, that it had closed a non-brokered private placement, consisting of 12.5 million units at a price of $0.12 per unit, to raise $1.5 million (http://nnw.fm/4v4sV). Each unit comprises one common share of the company and one common share purchase warrant. The warrant entitles the holder to purchase one common share at a price of $0.15 for a period of five years from closing. No finder’s fee was paid on this placement, and all securities issued are subject, in accordance with securities laws, to a four-month plus one day holding period from date of issue.
Global Hemp Group intends to use the proceeds for several purposes. Firstly, the capital will be used to fund the development of its New Brunswick hemp cultivation and extraction project. In conjunction with its joint venture partner, Marijuana Company of America (OTC: MCOA), Global Hemp Group completed its industrial hemp trials in northeast New Brunswick at the end of 2017. This marked the first harvest of hemp on the Acadian peninsula in 20 years. The partners have recruited hemp farmers to work 125 acres in 2018 and plan to increase the area under cultivation to over 1,000 acres within three years. Global Hemp will supply its considerable technical and management expertise for this project.
The proceeds will also be used to fund due diligence on potential acquisitions, namely in the State of Oregon, where Global Hemp Group is contemplating buying land for hemp cultivation and cannabinoid extraction. The funds will also be used to bolster the company’s working capital. Company insiders subscribed for a total amount of $371,542, representing 24.8 percent of the private placement.
Founded in 2014, Global Hemp Group is building a strategic portfolio of hemp-based companies to provide its global customer base with a consistent supply of high-quality hemp-derived products. It intends to leverage the huge market potential of hemp products to deliver significant ROI to its shareholders. The number of products that can be manufactured from the hemp plant is vast. It can be used to provide food, clothing, building materials, fuel and medicine. Additionally, its use for the development and production of cannabidiol (CBD)-based medical products has immense market potential. In the future, Global Hemp Group intends to establish several Hemp Agro-Industrial Zones (HAIZ) for the development of industrial hemp cultivation and processing facilities. The company plans to achieve the development of this concept through joint ventures, partnerships or acquisitions of companies involved in the farming, processing, manufacturing and distribution of hemp products.
The market for CBD-based medical products has witnessed a huge surge over the last year, and it is expected to grow at a CAGR of more than 39 percent over the next four years. The Hemp Business Journal (http://nnw.fm/jL3Pq) forecasts that the CBD market will grow to over $2 billion by 2020, with $450 million attributed to hemp-based cannabinoid medical products.
For more information, visit the company’s website at www.GlobalHempGroup.com